blank_Banner.png

Home

Who are we?

Cyclica harnesses biophysics, bioinformatics and artificial intelligence (AI) to help pharmaceutical companies navigate the drug discovery pipeline by assessing the safety and efficacy of drugs. Whether pre-clinical, clinical, or FDA approved, Cyclica's patented structure-based and AI-augmented platform, Ligand Express™ offers novel insight and analysis into a drug's polypharmacology.

By focusing on a small molecule structure and its polypharmacological profile, we distinguish ourselves with virtual screening technologies that are specific for a target protein structure. We further augment our structural information with AI to drive our biophysical simulations.

Cyclica's pre-clinical insights and in silico predictions improve current attrition rates of lead therapeutic compounds, improve patient outcomes with fewer side effects, and breathe life back into shelved therapeutics.

Ligand Express™

Ligand Express™

 
Our Documentation

Our Documentation

 
Our Team

Our Team

 
 
Our Successes

Our Successes

 
ACCELERATE YOUR RESEARCH WITH LIGAND EXPRESS™